Literature DB >> 10675761

Loss of ELISA specificity due to biotinylation of monoclonal antibodies.

G Høyer-Hansen1, M J Hamers, A N Pedersen, H J Nielsen, N Brünner, K Danø, R W Stephens.   

Abstract

A significant degree of nonspecificity was found in ELISA determinations of soluble urokinase receptor (suPAR) in human blood plasma when biotinylated monoclonal antibodies (Mabs) were used for the detection layer. Surface plasmon resonance studies using both nonbiotinylated and biotinylated antibodies demonstrated that biotinylation reduced specific binding of the antibodies to their target antigen, suPAR. Furthermore, biotinylation produced a new interaction with unknown human plasma protein(s), unrelated to suPAR. Nonspecific interaction with plasma protein(s) was also observed after biotinylation of a Mab having no specific target antigen in human plasma and, in both cases, the level of nonspecific interaction was directly related to the degree of antibody biotinylation. These results reinforce earlier observations that biotinylation of antibodies can reduce the affinity of antibodies, but also indicate that, in addition, biotinylation can reduce the specificity of immunoassays for plasma proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675761     DOI: 10.1016/s0022-1759(99)00222-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid.

Authors:  Xiping Cui; Natalia Vasylieva; Ding Shen; Bogdan Barnych; Jun Yang; Qiyi He; Zhengyun Jiang; Suqing Zhao; Bruce D Hammock
Journal:  Analyst       Date:  2018-04-30       Impact factor: 4.616

2.  Simultaneous protein expression and modification: an efficient approach for production of unphosphorylated and biotinylated receptor tyrosine kinases by triple infection in the baculovirus expression system.

Authors:  Dirk Erdmann; Catherine Zimmermann; Patrizia Fontana; Jean-Christophe Hau; Alain De Pover; Patrick Chène
Journal:  J Biomol Tech       Date:  2010-04

3.  High ErbB3 activating activity in human blood is not due to circulating neuregulin-1 beta.

Authors:  Emmanuel Boateng; Joanne T deKay; Sarah M Peterson; Jacob Boles; Nathan Pinnette; Mary W Sorcher; Michael P Robich; Douglas B Sawyer; Sergey Ryzhov
Journal:  Life Sci       Date:  2020-04-03       Impact factor: 5.037

4.  Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients.

Authors:  Jiwon Koh; Soo Kyung Nam; Youn Woo Lee; Jin Won Kim; Keun-Wook Lee; Chan-Young Ock; Do-Youn Oh; Sang-Hoon Ahn; Hyung-Ho Kim; Keon-Wook Kang; Woo Ho Kim; Ho-Young Lee; Hye Seung Lee
Journal:  Biomolecules       Date:  2019-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.